MyFinsight
Home
Blog
About
Contact
Download
Download image
Trade accounts and
other receivables
-$13,208,415
Depreciation and
amortization
$1,503,635
Trade accounts
payable
$650,309
Inventories
-$589,761
Provision to write down
inventories to net...
-$549,218
Other payables and
accrued expenses
$465,753
Depreciation of right of use
assets
$75,534
Advances to suppliers
-$8,334
Financial expense
-$3,472
Prepaid expenses
-$793
Net cash provided by
/ (used in)...
$148,261
Effect of exchange rate
changes on cash
$1,250
Canceled cashflow
$16,906,963
Net decrease in cash
and cash...
-$281,767
Canceled cashflow
$149,511
Proceeds from lines of
credit
$699,996
Proceeds from related
party
$261,070
Accounts written off to
allowance for credit...
-$13,664,945
Net loss
-$3,187,556
Contract liabilities
-$53,444
Credit (gains) loss
-$1,018
Net cash used in
financing activities
-$294,027
Canceled cashflow
$961,066
Net cash used in
investing activities
-$137,251
Payments of line of credit
$1,176,343
Principal payments on
finance lease...
$78,750
Advances for intangible
assets
$77,927
Purchases of property,
plant and equipment,...
$59,324
Back
Back
Cash Flow
source: myfinsight.com
CHINA PHARMA HOLDINGS, INC. (CPHI)
CHINA PHARMA HOLDINGS, INC. (CPHI)